Repository logo
 

The structure of the catalytic domain of the ATP synthase from Mycobacterium smegmatis is a target for developing antitubercular drugs.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Zhang, Alice Tianbu 
Montgomery, Martin G 
Leslie, Andrew GW 
Cook, Gregory M 

Abstract

The crystal structure of the F1-catalytic domain of the adenosine triphosphate (ATP) synthase has been determined from Mycobacterium smegmatis which hydrolyzes ATP very poorly. The structure of the α3β3-component of the catalytic domain is similar to those in active F1-ATPases in Escherichia coli and Geobacillus stearothermophilus However, its ε-subunit differs from those in these two active bacterial F1-ATPases as an ATP molecule is not bound to the two α-helices forming its C-terminal domain, probably because they are shorter than those in active enzymes and they lack an amino acid that contributes to the ATP binding site in active enzymes. In E. coli and G. stearothermophilus, the α-helices adopt an "up" state where the α-helices enter the α3β3-domain and prevent the rotor from turning. The mycobacterial F1-ATPase is most similar to the F1-ATPase from Caldalkalibacillus thermarum, which also hydrolyzes ATP poorly. The βE-subunits in both enzymes are in the usual "open" conformation but appear to be occupied uniquely by the combination of an adenosine 5'-diphosphate molecule with no magnesium ion plus phosphate. This occupation is consistent with the finding that their rotors have been arrested at the same point in their rotary catalytic cycles. These bound hydrolytic products are probably the basis of the inhibition of ATP hydrolysis. It can be envisaged that specific as yet unidentified small molecules might bind to the F1 domain in Mycobacterium tuberculosis, prevent ATP synthesis, and inhibit the growth of the pathogen.

Description

Keywords

F1-ATPase, Mycobacterium smegmatis, inhibition, structure, tuberculosis, ATP Synthetase Complexes, Antitubercular Agents, Bacterial Proteins, Diarylquinolines, Drug Resistance, Multiple, Bacterial, Humans, Mycobacterium smegmatis, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant

Journal Title

Proc Natl Acad Sci U S A

Conference Name

Journal ISSN

0027-8424
1091-6490

Volume Title

116

Publisher

Proceedings of the National Academy of Sciences
Sponsorship
Medical Research Council (MC_EX_MR/M009858/1)
Medical Research Council (MC_U105663150)
Medical Research Council (MC_UU_00015/8)
MRC (MC_UU_00015/8)
Medical Research Council (MC_UU_00015/7)
This work was supported by the Medical Research Council, U. K. by grants MC_U105663150 and MR/M009858/1 to J. E. W., and MC_U105184325 to A. G. W. L.; and by the European Drug Initiative on Channels and Transporters via contract HEALTHF4- 2007-201924 (EDICT) to J. E. W. G. M. C. was supported by a James Cook Fellowship from The Royal Society of New Zealand.